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VASCULAR SURGERY - II 
 
 
Foot complications in patients with diabetes 
 





Foot complications are a common cause of hospital admission of people with diabetes and a fre-
quent cause of amputation. Neuropathy and arterial disease make the foot particularly vulnerable, 
but infection is often the complication which precipitates presentation. Recognition of the patient 
at risk may prevent the development of foot complications, but if they do occur urgent treatment 
is required to prevent limb loss. The infected foot in a patient with diabetes is a surgical emer-
gency. In addition to antibiotics, debridement and surgical drainage of infection should be con-
sidered within the first 24 hours. Once the foot is made safe, reascularisation should be undertak-
en in those with significant arterial disease. Adoption of a multidisciplinary team approach to 
managing diabetic foot complications has resulted in reduction in major amputation in some Eu-
ropean countries. 
 






Diabetes is a common chronic disease which is rapidly increasing in prevalence. It is estimated 
to affect approximately 4.6 million people in the UK and it is forecast that by 2025 more than 5 
million people in the UK will have a diagnosis of diabetes. Complications of diabetes pose a sig-
nificant national financial burden, accounting for 9% of total NHS hospital costs, with manage-
ment of foot problems costing around £650 million a year and accounting for more admissions 
than any other diabetic complication.  
The lifetime risk of foot ulceration in those with diabetes is around 15% (although some recent 
evidence suggests it may be up to 25%), and the presence of ulceration is a major prognostic in-
dicator. More than 80% of lower limb amputations in UK diabetic patients were preceded by foot 
ulceration, and having a first amputation carries a high risk of subsequent further amputations. In 
addition, 5-year mortality following a diabetic foot ulcer is around 50%. 
 
 
The 2015 International Working Group on the Diabetic Foot (IWGDF) guidance identified pre-
vention as the most important aspect of management of the condition. Identification of the “at 
risk” foot with regular inspection and examination, education of patient and health care profes-
sionals, routine wearing of appropriate footwear and treatment of pre-ulcerative conditions will 




Aetiology and pathology 
 
Key risk factors for developing foot complications in diabetes are the presence of peripheral neu-
ropathy and/or peripheral artery disease (PAD), foot deformity, and previous history of ulcers or 
amputation of the toes or part of the foot. It has been estimated that of patients with foot compli-
cations approximately 25-44% are due to neuropathy, 10% are due to ischaemia and 45-60% are 





Diabetic polyneuropathy is one of the commonest complications of diabetes, affecting the feet of 
at least 28% of people with diabetes. The exact aetiology of the neuropathy is unclear but it is 
closely linked to the duration of diabetes and adequacy of glycaemic control. It is strongly asso-
ciated with the presence of retinopathy and nephropathy. Neuropathy affects sensory, motor and 




Sensory neuropathy results in loss of protective sensation, allowing injury to go unnoticed. 
Chronic repetitive injury, often from inappropriate footwear, may not become apparent until tis-
sue breakdown occurs. Impaired proprioception has negative effects on gait, and loss of the pro-
tective changes in biomechanical load distribution can result in sustained stress and tissue dam-
age. In some patients, sensory nerve damage results in pain or allodynia (perception of pain on 
light touch). 
 
Motor Neuropathy  
 
Diabetic neuropathy predominantly affects the small peripheral nerves. The intrinsic muscles of 
the foot, predominantly flexors, are affected more than the extensor groups in the calf. This im-
balance results in clawing of the toes and prominence of the metatarsal heads, with loss of the 
protective plantar fat pads. This makes the foot very prone to injury from both friction by foot 
wear and abnormal weight distribution (Figure 1). The first clinical sign to look out for is callus 
formation; its rigidity causes even greater pressure on the tissue beneath, and may crack and fis-




Loss of sweating occurs results in dry skin that is prone to cracking and infection. Autonomic 
regulation of skin blood flow may be lost, increasing shunting through arterial venous fistulae, 









Peripheral artery disease (PAD) 
 
PAD due to atherosclerosis is four times more common in patients with diabetes and around half 
of patients with a diabetic foot ulcer have co-existing PAD. Atherosclerotic plaque in patients 
with diabetes contains more calcium and has increased expression of inflammatory markers, per-
haps explaining the more aggressive progression of the disease. Macroscopically the disease af-
fects more distal vessels, particularly in the calf and foot (Figure 2). Patients with diabetes are 
less likely to form collaterals after vessel occlusion.  
Identifying PAD, even if asymptomatic, in patients with foot ulceration is important because its 
presence is associated with worse outcomes, such as slow or non-healing of wounds, higher risk 




The microcirculation is not directly affected by atherosclerosis, but diabetes does affect the mi-
crocirculation in a number of ways. There are vasomotor abnormalities (see above) which may 
reduce capillary flow in the skin. There is thickening of vascular endothelial cells, with associat-
ed increased permeability and platelet aggregation. These observations help explain how wounds 
which are healthy and bleeding at the time of surgery can deteriorate and die back as the vessels 
in the microcirculation thrombose. It is important to appreciate how the effects of PAD are com-
pounded by microcirculatory abnormalities. What might seem a relatively minor lesion in a large 






The immune response of patients with diabetes may be abnormal. Neutrophil phagocytosis is 
impaired, not only increasing the risk of infection but also potentially masking the clinical re-
sponse. Only about one third of patients with a foot infection will be pyrexial and the white cell 
count may not be elevated despite extensive infection. Infection is often the final common path-





It is a common misconception that diabetes in itself causes delayed wound healing. There are 
numerous experimental studies that suggest this is not the case, however the co-existence of 










This is an uncommon complication of diabetic neuropathy. It often follows minor trauma such as 
a sprain and the foot becomes red, hot and swollen (Figure 3). It is a non-infectious, acute in-
flammatory state with rapid destruction of bones in the foot. It can be difficult to distinguish 
from infection and may be misdiagnosed, but the absence of a wound, marked swelling and de-
formity should prompt the diagnosis and referral to a specialist team. Weight bearing radiographs 
+/- MR scans may show bone destruction and in the absence of an open wound this should raise 
the suspicion of Charcot arthropathy. 
 
Treatment involves offloading the foot mechanically to prevent further stress and injury, prefera-
ble with a non-removable offloading casting device. Bisphosphonates should only be offered as 





Everyone with diabetes should undergo a foot assessment at least once a year, which should con-






A history of cardiovascular disease increases the likelihood of underlying arterial disease. Ulcers 
which are painful are more likely to be ischaemic but neuropathy may mask this. Despite the 
presence of arterial disease, the foot may appear well perfused and warm due to autonomic neu-
ropathy.  
 
Clinical examination, including palpation of pulses, should be performed, and the absence of 
pulses should prompt further investigation. As a diagnostic test for PAD, however, both the posi-
tive and negative predictive values of pulse palpation are poor, and it should be appreciated in 
particular that the presence of pedal pulses does not necessarily exclude PAD. It does however 
help to identify those at risk of subsequent ulceration or amputation. 
 
Ankle-brachial pressure index (ABPI) is a widely used non-invasive test which can be used for 
screening; peripheral artery disease is suggested if the ABPI is <0.9, however this may be arte-
factually raised in people with diabetes who may have calcified incompressible lower limb ves-
sels. Toe pressures or toe-brachial index (TBI) are likely to be more meaningful due to relative 
sparing of the pedal arteries. Whilst ABPI and toe pressures give useful information regarding 
large vessel disease, transcutaneous oxygen pressure measurement (TcpO2), if available, gives 
additional information regarding the microcirculation. Other non-invasive screening tests that 
can be used include ankle pressure, and distal tibial waveform on ultrasound. In a recent study 
comparing all these tests to a gold standard (significant disease on duplex ultrasound), the posi-
tive and negative likelihood ratios were all unsatisfactory, however distal tibial waveforms and 
TBI may be useful in identifying patients who need further diagnostic tests. 
 
 
For further morphological evaluation of arterial disease, an arterial duplex ultrasound scan would 
be the most appropriate next investigation. This is readily available, inexpensive and non-
invasive. In selected patients, more detailed imaging may be required, especially in supra-
inguinal vessels. CT angiography can give clear pictures of the vessels and is relatively non-
invasive (Figure 4), although the interpretation of both duplex and CT are limited by calcifica-
tion, especially of the crural vessels; a common feature of PAD in patients with diabetes. MR 
angiography can be used but has several disadvantages; it is usually less easily accessible than 
other imaging modalities, patients may find the scanner claustrophobic, and the contrast agent 
gadolinium can cause systemic interstitial fibrosis in patients with impaired renal functio Also, 
due to artefact, interpretation of vascular MR images can be difficult and requires a radiologist 






This should constitute assessment of sensory, motor and autonomic neuropathy. On biomechani-
cal inspection, callus formation on weight bearing areas and changes in foot shape can be indica-
tors of neuropathy. Dry cracked skin suggests autonomic involvement. Screening for sensory 
neuropathy is important as this may have gone unnoticed by the patient. The Ipswich toe touch 
test is a useful screen; with the patient’s eyes closed, the tester very lightly touches 6 random 
toes individually and records the reporting of sensation by the patient. An alternative widely used 
test is the 10g monofilament test to light touch on 10 sites in the foot and / or a 128Hz tuning 
fork on the great toe to assess vibration sensation.  
 
Although nociception is commonly impaired in patients with diabetic foot problems, foot pain in 
someone with diabetes and a foot ulcer should be taken very seriously, as it may be a sign of se-






Careful wound assessment must be undertaken to determine the depth and involvement of deep 
structures such as bone, tendon and joints. This can be done by clinical examination and probing 
the wound for bone in the wound base. Palpation may elicit a discharge of pus which has tracked 
up the tendon sheaths. Plain radiographs should reveal radiological signs of long-standing oste-
omyelitis, but may not detect early changes. They may also gas in the tissues (figure 6). MR im-
aging can be used as an adjunct to help plan the extent of resection required, but is often unhelp-
ful in the acute situation. . Foot ulcers may be classified using the SINBAD (Site, Ischaemia, 
Neuropathy, Bacterial Infection, Area and Depth) classification. A score of 0 or 1 is given for 
each component, up to a maximum score of 6.  
 
The WIfI classification is another very useful systemsystem, which has been widely adopted. It 
comprises three components; wound, ischaemia and foot infection, and is graded from 0 to 3 
(Table 1). This differs from (and is arguably more valuable than) previous classification systems 
 
 
firstly in that it distinguishes gangrene from ulcers, and more importantly in that it aims to define 
the disease burden in a meaningful way. This gives useful information on the potential benefit 





The management of people with diabetes at risk of foot complications requires seamless working 
across both primary and secondary care. The multi-disciplinary team should include podiatrists, 
specialist nurses, diabetic physicians, general practitioners, vascular and orthopaedic surgeons, 
orthotists and microbiologists. There should be a clear pathway of care agreed by all those in-
volved and the roles of each member of the team defined.  
 
NICE divides guidance on management of the foot in diabetes into care for those with and those 
without (but at risk of) a foot lesion.  
 
 
Management of the at-risk patient with diabetes 
 
All people with diabetes should have at least an annual foot examination as described above, 
which allows the risk of future ulceration to be stratified. All patients should be told of their risk 
level and given oral and written advice about foot care and diabetes control. Those identified as 
low risk should continue having annual reviews. Referral to the foot protection service should be 
made for those whose risk is moderate (within 6-8 weeks) or high (within 2-4 weeks). Those at 
moderate risk should continue to be reviewed every 3-6 months, and those at high risk every 1 
week to 2 months. 
 
Careful monitoring by a clinician with the relevant expertise will identify early problems and al-
low intervention and correction (e.g. better footwear) before significant tissue damage occurs. 




Management of the diabetic patient with a foot ulcer 
 
The broad principles of management of the diabetic foot ulcer are control of infection, metabolic 
control and treatment of comorbidity, restoration of skin perfusion (treatment of PAD), local 
wound care, relief of pressure and protection of the ulcer (offloading), education and prevention 
of recurrence. Figure 5 summarises the management of an acute diabetic foot problem. 
 
If a diabetic foot problem is detected in the community, patients should be referred to a multidis-
ciplinary foot care service within 1 working day, unless the condition is life or limb threatening 
(e.g. ulceration with sepsis or critical ischaemia), in which case they should be admitted to hospi-
tal acutely. Following admission, the patient should be referred to an inpatient multidisciplinary 
foot team within 24 hours. Delays in referral from primary care are, unfortunately, common; it is 
of paramount importance that all members of the clinical team appreciate that delays in treatment 
 
 
of acute diabetic foot problems costs limbs, and larger wounds at presentation are more difficult 
to heal.  
 
 
Control of infection 
 
Infection is the most common cause of acute presentation. Sepsis severity may be masked in dia-
betic patients by the lack of ability to feel pain and a lack of systemic response. Inflammatory 
markers may be normal in patients with diabetes and deranged glycaemic control may be the on-
ly indicator of infection. As such, any foot infection in a diabetic patient should be treated ag-
gressively, with a low threshold for admission and intravenous antibiotics.  
 
Early wound debridement is beneficial and, if possible, a soft tissue or bone sample or a 
deep wound swab should be obtained for culture and sensitivity to guide antibiotic treatment Os-
teomyelitis should always be considered and excluded in these patients, however MRI is rarely 
helpful in patients presenting with new onset severe diabetic foot infection. Deep seated spread-
ing infection or extensive necrotic tissue with sepsis is a surgical emergency, and debridement 
should be performed as soon as possible to make the condition safe. Following debridement, of-
floading of the ulcer is very important, and is discussed further below. In cases of severe uncon-
trollable sepsis, amputation may be the only life-saving option. In these situations, a guillotine 
amputation is preferred to remove all infected material, with the amputation revised later when 
the patient is optimised.  
 
Metabolic control and treatment of co-morbidities 
 
Blood glucose control may be acutely deranged in the context of infection, and should be moni-
tored and, if necessary, controlled with an insulin sliding scale. Chronic poor blood glucose con-
trol is associated with an increased risk of peripheral artery disease and long-term diabetic foot 
problems, and advice should be sought from the diabetes team if this is suspected. 
 
Diabetic patients with an ischaemic foot ulcer have a high cardiovascular risk, and as such they 
should be risk assessed, prescribed a statin and antiplatelet, treated for existing hypertension and 
receive smoking cessation support.  
 
 
Revascularisation and restoration of skin perfusion 
 
Up to 50% of diabetic patients with a foot ulcer have peripheral artery disease (PAD), therefore 
they should all undergo vascular assessment. PAD in diabetic patients is associated with worse 
outcomes, including non-healing ulcers, amputation, cardiovascular events and death. Diagnosis 
can be challenging because diabetic patients may not display the typical symptoms of PAD, and 
bedside tests can be unreliable. Urgent vascular imaging and revascularisation should be consid-
ered in those with toe pressures of <30mmHg or transcutaneous oxygen tension (TcPO2) less 
than 25mmHg, or <50mmHg with a non-healing ulcer, or a high clinical suspicion. Where PAD 
is present, early revascularisation increases the chance of wound healing. In suitable patients, 
endovascular and open surgery should be considered and discussed in a vascular MDT setting. 
 
 
There is no strong evidence for one technique over another, and the merits of each should be 
considered on a case by case basis depending on patient co-morbidities, anatomical distribution 
of the vascular lesions(s) and local skill set. 
 
It is important to appreciate that, contrary to previous belief, there is no evidence of difference in 
patency rates of revascularisation in patients with diabetes compared to those without. These pa-




The basic principles of wound care are to remove any dead or infected tissue from the wound 
environment and to keep the wound surface and surrounding skin as clean and dry as possible as 
possible to avoid maceration. Following debridement, offloading the wound is of critical im-
portance to remove pressure during the healing period, and can be achieved with bed rest, casting 
or offloading removable adapted footwear. Wide surgical excision of the chronic wound, with or 
without underlying bone, may have a role in reducing time to healing, although the current evi-
dence base is not strong. It is generally accepted that surgical foot wounds should be left to heal 
by secondary intention. Suturing the wound may prevent adequate drainage of infection and puts 
extra pressure on the wound edge, risking necrosis. 
 
A variety of dressing types have been advocated, many with limited or no evidence to support 
their use, or to recommend one over another.  Further high quality evidence is needed to guide 
dressing choices. More complex dressings and treatments should only be utilised when the sim-
ple, evidence-based interventions have failed.  
 
The use of negative pressure wound therapy has a potential role in the management of post sur-
gery acute foot wounds. There is some promising evidence that it increases the rate of wound 
healing and portable devices permit an early return to the home environment, however it is cur-
rently only recommended for post-operative wounds as opposed to chronic wounds. Further 
high-quality studies are needed to evaluate its use in chronic foot wounds.  Dermal and skin sub-
stitutes can be considered as an adjunct when healing has not progressed with standard care. For 
extensive tissue loss in patients with good blood supply more complex reconstructions can be 








After initial wound treatment offloading the foot is crucial. In the early stages, bed rest and foot 
elevation will reduce oedema and its inhibitory effects on healing. During this time, DVT 
prophylaxis should be prescribed if indicated, and prevention of new pressure related ulcers is of 







Education and Prevention of Recurrence 
 
When a patient leaves hospital it is essential to ensure that they are aware of the risks of further 
foot problems and take precautions to avoid them. Appropriate foot wear, access to regular fol-
low up and a point of contact if there is deterioration are all important. If the patient has under-
gone an amputation then advice and care are needed to prevent problems with the stump and 
with the remaining foot.  
 
Encouragingly there is increasing evidence that implementation of clear policies to identify pa-
tients at risk and to intervene early in those who develop complications can have a major impact 
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Figure 1. Foot of patient with diabetes. Dry, flaky skin due to the autonomic neuropathy can be 
seen. The clawing of the toes secondary to the motor neuropathy which has resulted in 
rubbing of the toes and dorsum of the foot on the patients shoe, which he was unaware of 
due to reduced sensation. 
 
Figure 2.Angiogram of patient with extensive peripheral artery disease affecting the calf arteries. 
 
Figure 3. Charcot’s neuroarthropathy. A swollen red hot foot. A total contact cast has recently 
been removed. 
 
Figure 4. CT angiogram of patient with peripheral artery disease. 
 
Figure 5. Algorithm overview of the approach of the patient with diabetes and a foot infection.     
 












 WOUND ISCHAEMIA (primary de-
terminant is toe pressures) 
FOOT INFECTION 
0 0 = no ulcer, no gangrene 0 = TP >59 mmHg 0 = no infection 
1 1= small, shallow ulcer & 
no gangrene 
1 = TP 40-59 mmHg 1 = mild, superficial 
(<2cm cellulitis) 
2 2 = deeper, larger ulcer & 
gangrene limited to toes 
2 = TP 30-39 mmHg 2 = moderate, deeper 
(>2cm cellulitis) 
3 3 = extensive ulcer & ex-
tensive gangrene 
3 = TP <30 mmHg 3 = severe & SIRS 
 
